235 related articles for article (PubMed ID: 1729263)
1. Mitotic indexes as prognostic predictors in female breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
J Cancer Res Clin Oncol; 1992; 118(1):75-81. PubMed ID: 1729263
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in axillary lymph node-negative (pN-) breast carcinomas.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Eur J Cancer; 1991; 27(12):1555-9. PubMed ID: 1782062
[TBL] [Abstract][Full Text] [Related]
3. Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Int J Cancer; 1991 Dec; 49(6):886-92. PubMed ID: 1959993
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of a morphometric prognostic index in female breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Oncology; 1993; 50(1):57-62. PubMed ID: 8421599
[TBL] [Abstract][Full Text] [Related]
5. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
Eur J Surg; 1991 May; 157(5):319-24. PubMed ID: 1678644
[TBL] [Abstract][Full Text] [Related]
6. Volume corrected mitotic index (M/V index), mitotic activity index (MAI), and histological grading in breast cancer.
Lipponen PK; Collan Y; Eskelinen MJ
Int Surg; 1991; 76(4):245-9. PubMed ID: 1663917
[TBL] [Abstract][Full Text] [Related]
7. Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Am J Surg; 1993 Mar; 165(3):307-11. PubMed ID: 8447534
[TBL] [Abstract][Full Text] [Related]
8. Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Eur Surg Res; 1992; 24(3):160-8. PubMed ID: 1499604
[TBL] [Abstract][Full Text] [Related]
9. The significance of nuclear morphometric variables as prognostic predictors in breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Anticancer Res; 1991; 11(4):1663-9. PubMed ID: 1746922
[TBL] [Abstract][Full Text] [Related]
10. DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer.
Eskelinen M; Lipponen P; Papinaho S; Aaltomaa S; Kosma VM; Klemi P; Syrjänen K
Int J Cancer; 1992 Jun; 51(4):555-61. PubMed ID: 1601520
[TBL] [Abstract][Full Text] [Related]
11. Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Anticancer Res; 1991; 11(5):1701-6. PubMed ID: 1768039
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.
Lipponen P; Papinaho S; Eskelinen M; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
Anticancer Res; 1992; 12(5):1533-8. PubMed ID: 1444217
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapy.
Manders P; Bult P; Sweep CG; Tjan-Heijnen VC; Beex LV
Breast Cancer Res Treat; 2003 Jan; 77(1):77-84. PubMed ID: 12602906
[TBL] [Abstract][Full Text] [Related]
14. The value of morphometry to classic prognosticators in breast cancer.
Baak JP; Van Dop H; Kurver PH; Hermans J
Cancer; 1985 Jul; 56(2):374-82. PubMed ID: 4005802
[TBL] [Abstract][Full Text] [Related]
15. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
Lipponen PK; Eskelinen MJ; Kiviranta J; Nordling S
Anticancer Res; 1991; 11(2):911-6. PubMed ID: 2064350
[TBL] [Abstract][Full Text] [Related]
16. Histological assessment of the prognostic factors in female breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Mari S; Alhava E; Syrjänen K
Oncology; 1992; 49(1):1-8. PubMed ID: 1542486
[TBL] [Abstract][Full Text] [Related]
17. Independent clinical, histological and quantitative prognostic factors in transitional-cell bladder tumours, with special reference to mitotic frequency.
Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
Int J Cancer; 1992 May; 51(3):396-403. PubMed ID: 1592531
[TBL] [Abstract][Full Text] [Related]
18. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
19. Morphometric grading in breast cancer: thresholds for mitotic counts.
Kronqvist P; Kuopio T; Collan Y
Hum Pathol; 1998 Dec; 29(12):1462-8. PubMed ID: 9865834
[TBL] [Abstract][Full Text] [Related]
20. In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up.
Bult P; Manders P; Straatman HM; Tjan-Heijnen VC; Beex LV; Hendriks J; Leer JW; Verbeek AL; Holland R
Breast Cancer Res Treat; 2010 Jul; 122(1):77-86. PubMed ID: 19760038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
